BioSpace News Archive

Ncardia announced today that following retraction of the Cor.4U product line from the market and resulting insolvency of its former legal entity in Germany (operating under the name Ncardia AG / former Axiogenesis), it has accelerated investment in its manufacturing site in Belgium, R&D and drug discovery center in the Netherlands, and commercial operations in the USA.

Morris Animal Foundation-funded researchers at the University of Illinois identified a new fungus that could be a significant emerging pathogen of freshwater turtles.

KESSEL MEDintim, WCG Cares (WCG) and Population Services International (PSI) announced the launch of the Caya™ Diaphragm and Caya™ Gel in Niger.

McDermott Will & Emery (McDermott), the nation’s leading healthcare law firm, has an established track record of supporting healthcare systems seeking innovative partnerships to advance care in a rapidly changing market.

LHF-535, Kineta’s lead biodefense asset, is a novel once-daily oral antiviral drug currently being evaluated in Phase 1 safety trials in healthy volunteers.

SpeeDx Pty. Ltd. today announced ResistancePlus® MG has been cleared by Health Canada and is now available for sale across all Canadian provinces (not currently available in the U.S.).

Paige, the leader in computational pathology focused on building artificial intelligence (AI) to transform the clinical diagnosis and treatment of cancer, today announced the publication of an article in Nature Medicine, a leading monthly journal publishing original peer-reviewed research in all areas of medicine, describing an AI system for computational pathology that achieves clinical-grade accuracy levels.

A recent digital supplement from The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, addresses follicular lymphoma (FL) and the phosphatidylinositol 3-kinase (PI3K) pathway as an emerging treatment option.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 second quarter financial results for Thursday, August 1, 2019 before the market opens.

Late last week, a U.S. District Court judge in Maryland issued a decision that, among other things, requires makers and importers of e-cigarettes and other electronic nicotine delivery systems (ENDS) and certain other tobacco products like cigars, pipe tobacco and hookah to submit applications for their currently marketed products to the agency within 10 months.